share_log

Barrington Research Reiterates Outperform on Dentsply Sirona, Maintains $41 Price Target

Benzinga ·  Mar 1 10:47

Barrington Research analyst Michael Petusky reiterates Dentsply Sirona (NASDAQ:XRAY) with a Outperform and maintains $41 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment